Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the Use of Dapagliflozin in Diuresis, Natriuresis and in Ultrafiltration and Peritoneal Elimination of Sodium, in Patients With Refractory Heart Failure

NCT06578520 is registered in ClinicalTrials.gov with Fundación para la Investigación del Hospital Clínico de Valencia as lead sponsor.

NCT NCT06578520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06578520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the Use of Dapagliflozin in Diuresis, Natriuresis and in Ultrafiltration and Peritoneal Elimination of Sodium, in Patients With Refractory Heart Failure
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Phase
Phase 4
Overall status
Active, not recruiting
Start date
July 30, 2024
Completion date
December 31, 2026
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure